COPD is a progressive lung disease with mild symptoms in the early stages ... 1 to stage 4 COPD. Doctors determine the severity of your symptoms using either the British Medical Research Council ...

A four-phased brand repositioning approach will help ... and stretch the brand. The purpose of Phase III is to use all marketing research, brand, industry, and consumer information to reposition what ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle ...

For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...

Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...

The field of central nervous system (CNS) drug development is awash with activity. And major new centres of research are ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Paradigm Biopharmaceuticals has selected Advanced Clinical as the preferred clinical research organisation for the phase III trial for PARA_OA_012. Advanced Clinical has a proven track record in ...